ENDURACELL Trademark

Trademark Overview


On Friday, May 25, 2018, a trademark application was filed for ENDURACELL with the United States Patent and Trademark Office. The USPTO has given the ENDURACELL trademark a serial number of 79240725. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, January 16, 2026. This trademark is owned by Cell-Logic Pty Ltd. The ENDURACELL trademark is filed in the Pharmaceutical Products category with the following description:

Anti-bacterial pharmaceutical preparations; anti-cancer pharmaceutical preparations; meal for pharmaceutical purposes; pharmaceutical preparations for the therapeutic treatment of diabetes mellitus; pharmaceutical preparations for the treatment of alcoholism; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of cardiovascular disorders; pharmaceutical preparations for the treatment of depressive illness; pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of digestive maladies; pharmaceutical preparations for the treatment of disorders of the central nervous system; pharmaceutical preparations for the treatment of disorders of the gastro-enterological tract; pharmaceutical preparations for the treatment of gastric diseases; phar...
enduracell

General Information


Serial Number79240725
Word MarkENDURACELL
Filing DateFriday, May 25, 2018
Status709 - CANCELLED - SECTION 71
Status DateFriday, January 16, 2026
Registration Number5790674
Registration DateTuesday, July 2, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 16, 2019

Trademark Statements


Goods and ServicesAnti-bacterial pharmaceutical preparations; anti-cancer pharmaceutical preparations; meal for pharmaceutical purposes; pharmaceutical preparations for the therapeutic treatment of diabetes mellitus; pharmaceutical preparations for the treatment of alcoholism; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of cardiovascular disorders; pharmaceutical preparations for the treatment of depressive illness; pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of digestive maladies; pharmaceutical preparations for the treatment of disorders of the central nervous system; pharmaceutical preparations for the treatment of disorders of the gastro-enterological tract; pharmaceutical preparations for the treatment of gastric diseases; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of joint related diseases; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for use in the treatment of arthritis; pharmaceutical preparations for use in the treatment of hormonal disorders; pharmaceutical preparations for use in the treatment of muscle tension; pharmaceutical preparations for use in the treatment of rheumatism; pharmaceutical preparations for use in the treatment of sciatica; pharmaceutical products for combating heart diseases; pharmaceutical products for combating metabolism disorders; pharmaceutical products for the treatment of cardiovascular disorders; pharmaceutical products for the treatment of gastrointestinal disorders; pharmaceutical products for the treatment of osteoporosis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 16, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCell-Logic Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAU

Party NameCell-Logic Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAU

Party NameCell-Logic Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAU

Trademark Events


Event DateEvent Description
Thursday, September 13, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, September 19, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 19, 2018ASSIGNED TO EXAMINER
Tuesday, September 25, 2018APPLICATION FILING RECEIPT MAILED
Thursday, September 27, 2018NON-FINAL ACTION WRITTEN
Friday, September 28, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, October 1, 2018REFUSAL PROCESSED BY MPU
Monday, October 1, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, October 19, 2018REFUSAL PROCESSED BY IB
Thursday, January 17, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 17, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 17, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 26, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 27, 2019NOTICE OF PUBLICATION
Tuesday, April 16, 2019PUBLISHED FOR OPPOSITION
Tuesday, July 2, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, October 2, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, October 19, 2019FINAL DISPOSITION PROCESSED
Saturday, October 19, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, November 8, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, January 16, 2026CANCELLED SECTION 71